Related Experiment Video
Updated: May 2, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Diabetic control and coronary artery bypass: effect on short-term outcomes
Stephen Strahan1, Ryan M Harvey, Andrew Campbell-Lloyd
1Department of Cardiac Surgery, Princesses Alexandria Hospital, Brisbane, Queensland, Australia.
Insights
Preoperative glycemic control and treatment type did not impact short-term outcomes for diabetic patients undergoing coronary artery bypass grafting. Strict perioperative glucose management may explain these findings.
Area of Science:
- Cardiology
- Diabetology
- Surgical Outcomes
Background:
- Diabetic patients represent a significant portion of individuals undergoing coronary artery bypass grafting (CABG).
- Preoperative glycemic control is a critical factor influencing surgical outcomes in diabetic patients.
- Understanding the impact of glycemic control on morbidity and mortality in CABG is essential for optimizing patient care.
Purpose of the Study:
- To investigate the association between preoperative glycemic control and hospital morbidity and mortality.
- To evaluate the effect of different diabetic treatment modalities on outcomes in patients undergoing primary CABG.
- To compare outcomes between diabetic patients and a non-diabetic control group.
Main Methods:
- A retrospective analysis of prospectively collected data from 3857 patients undergoing primary CABG.
- Categorization of 1109 diabetic patients based on treatment (diet, oral hypoglycemic agents, insulin) and glycemic control (hemoglobin A1c <7% vs. ≥7%).
- Comparison of complication rates between diabetic subgroups and 2748 non-diabetic controls.
Main Results:
- Diabetic patients exhibited higher prevalence of preoperative risk factors like hypertension, hyperlipidemia, renal failure, peripheral vascular disease, and COPD.
- No significant difference in major complications between diabetic and control groups (p=0.33).
- Minor complications were less frequent in diabetic patients (p=0.03), with no significant differences among treatment or glycemic control subgroups.
Conclusions:
- Preoperative glycemic control and treatment type did not significantly affect short-term morbidity or mortality in diabetic patients undergoing primary CABG.
- Strict protocol-driven glycemic control during the perioperative period may mitigate the impact of preoperative glycemic status.
- These findings suggest that standardized perioperative glucose management is crucial for diabetic patients undergoing cardiac surgery.
Aim:
To evaluate the effect of preoperative glycemic control on hospital morbidity and mortality in diabetic patients undergoing primary coronary artery bypass grafting.
Methods:
Data of 3857 patients undergoing primary coronary artery bypass grafting was prospectively collected and retrospectively analyzed. There were 1109 (29%) diabetic patients, of whom 712 (64%) had hemoglobin A1c levels recorded. They were categorized by diabetic treatment: diet (179), oral hypoglycemic agent, (718) or insulin (212); and by diabetic control: hemoglobin A1c < 7 (265) or ≥7 (447). Nondiabetic patients (2,748) were used as controls.
Results:
The preoperative risk factors of hypertension (p < 0.001), hyperlipidemia (p < 0.001), renal failure (p < 0.04), peripheral vascular disease (p < 0.001), and chronic obstructive pulmonary disease (p < 0.04) were significantly more prevalent in diabetic patients. Major complications were not significantly different between the diabetic and control groups (p = 0.33), but minor complications were less frequent in diabetic patients (p = 0.03). Major and minor complications were not significantly different among the treatment subgroups of diabetic patients (p = 0.74 and p = 0.48) or in those with hemoglobin A1c < 7 and ≥7 (p = 0.23, p = 0.41).
Conclusions:
Short-term outcomes were not affected by the degree of preoperative glycemic control or type of treatment used in diabetic patients undergoing primary coronary artery bypass grafting. A plausible explanation is strict protocol-driven glycemic control in the perioperative period.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Complications of Diabetes Mellitus
Coronary Artery Disease IV: Preventive Measures
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetic Retinopathy

